Advanced in Brain Tumor

Dr. Jeffrey D. Bradley

Radiation Oncology
Penn Medicine
Penn Radiation Oncology Perelman-Concourse Level
3400 Civic Center Boulevard, Concourse Level, 
Philadelphia, PA 
On Staff At
Accepting New Patients
Offers Telehealth
Advanced in Brain Tumor
Penn Medicine
Penn Radiation Oncology Perelman-Concourse Level
3400 Civic Center Boulevard, Concourse Level, 
Philadelphia, PA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Jeffrey Bradley is a Radiation Oncologist in Philadelphia, Pennsylvania. Dr. Bradley is rated as an Advanced provider by MediFind in the treatment of Brain Tumor. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and Thymic Epithelial Tumor. Dr. Bradley is currently accepting new patients.

His clinical research consists of co-authoring 219 peer reviewed articles and participating in 9 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 9 articles and participated in 1 clinical trial in the study of Brain Tumor.

Graduate Institution
University Of Arkansas College Of Medicine
Residency
North Shore University Hospital
Specialties
Radiation Oncology
Licenses
Radiology in MO
Board Certifications
Radiation Oncology, 1998
Hospital Affiliations
Hospital Of Univ Of Pennsylvania
Chester County Hospital
Penn Presbyterian Medical Center
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Clover Health
  • INSURANCE PLAN
  • MEDICARE MAPD
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Geisinger
  • HMO
  • POS
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
Provider Partners Health Plan
  • MEDICARE SNP
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
UPMC
  • EPO
  • PPO
View 10 Less Insurance Carriers -

Locations

Penn Radiation Oncology Perelman-Concourse Level
3400 Civic Center Boulevard, Concourse Level, Philadelphia, PA 19104
Call: 800-789-7366

Additional Areas of Focus

Dr. Bradley has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Lung Cancer

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

9 Clinical Trials

A Single-Arm Phase II Study With a Safety Lead-in of Magnetic Resonance-Guided Hypofractionated Adaptive Radiation Therapy With Concurrent Chemotherapy and Consolidation Durvalumab for Inoperable Stage IIB, IIIA, and Select IIIB and IIIC Non-small Cell Lung Cancer
A Single-Arm Phase II Study With a Safety Lead-in of Magnetic Resonance-Guided Hypofractionated Adaptive Radiation Therapy With Concurrent Chemotherapy and Consolidation Durvalumab for Inoperable Stage IIB, IIIA, and Select IIIB and IIIC Non-small Cell Lung Cancer
Enrollment Status: Completed
Publish Date: November 12, 2025
Intervention Type: Drug, Device, Biological, Radiation
Study Drugs: Paclitaxel, Carboplatin AUC, Durvalumab
Study Phase: Phase 2
A Phase II Study of Proton Beam Therapy in the Treatment of Esophageal Cancer
A Phase II Study of Proton Beam Therapy in the Treatment of Esophageal Cancer
Enrollment Status: Active_not_recruiting
Publish Date: April 06, 2025
Intervention Type: Radiation, Other
Study Phase: Not Applicable
Phase III Randomized Trial Comparing Overall Survival After Photon Versus Proton Chemoradiotherapy for Inoperable Stage II-IIIB NSCLC
Phase III Randomized Trial Comparing Overall Survival After Photon Versus Proton Chemoradiotherapy for Inoperable Stage II-IIIB NSCLC
Enrollment Status: Active_not_recruiting
Publish Date: December 18, 2024
Intervention Type: Other, Drug, Biological, Radiation
Study Drugs: Carboplatin, Cisplatin, Durvalumab, Etoposide, Paclitaxel, Pemetrexed Disodium
Study Phase: Phase 3
A Virtual Clinical Trial to Assess the Impact of Dual-Energy CT on Plan Quality, Dose-delivery Accuracy, and Simulated Outcomes of Patients Treated With Proton or Photon Therapy
A Virtual Clinical Trial to Assess the Impact of Dual-Energy CT on Plan Quality, Dose-delivery Accuracy, and Simulated Outcomes of Patients Treated With Proton or Photon Therapy
Enrollment Status: Terminated
Publish Date: March 01, 2024
Intervention Type: Device
Study Phase: Not Applicable
Registry for Proton Beam Radiation Therapy
Registry for Proton Beam Radiation Therapy
Enrollment Status: Completed
Publish Date: July 24, 2023
Randomized Phase II Trial of Individualized Adaptive Radiotherapy Using During-Treatment FDG-PET/CT and Modern Technology in Locally Advanced Non-Small Cell Lung Cancer (NSCLC)
Randomized Phase II Trial of Individualized Adaptive Radiotherapy Using During-Treatment FDG-PET/CT and Modern Technology in Locally Advanced Non-Small Cell Lung Cancer (NSCLC)
Enrollment Status: Unknown
Publish Date: April 29, 2021
Intervention Type: Drug, Procedure, Radiation, Other
Study Drugs: 18F-Fluoromisonidazole, Carboplatin, Fludeoxyglucose F-18, Paclitaxel
Study Phase: Phase 2
Objective Treatment Allocation With SBRT vs. Surgery in High Risk Patients With Early Stage Lung Cancer Within an Accountable Care Collaborative Effort Between Surgery and Radiation Oncology
Objective Treatment Allocation With SBRT vs. Surgery in High Risk Patients With Early Stage Lung Cancer Within an Accountable Care Collaborative Effort Between Surgery and Radiation Oncology
Enrollment Status: Completed
Publish Date: April 08, 2021
Intervention Type: Behavioral
Study Phase: Not Applicable
A Phase I/II Trial of Stereotactic Body Radiation Therapy (SBRT) Dose Escalation in the Treatment of Patients With Inoperable Stage I/II Non-Small Cell Lung Cancer Arising Within the Zone of the Proximal Bronchial Tree
A Phase I/II Trial of Stereotactic Body Radiation Therapy (SBRT) Dose Escalation in the Treatment of Patients With Inoperable Stage I/II Non-Small Cell Lung Cancer Arising Within the Zone of the Proximal Bronchial Tree
Enrollment Status: Completed
Publish Date: July 30, 2019
Intervention Type: Radiation
Study Phase: Phase 1/Phase 2
Phase I/II Trial of Lithium as a Neuroprotective Agent for Patients With Small Cell Lung Cancer (SCLC) Treated With Prophylactic Cranial Irradiation (PCI)
Phase I/II Trial of Lithium as a Neuroprotective Agent for Patients With Small Cell Lung Cancer (SCLC) Treated With Prophylactic Cranial Irradiation (PCI)
Enrollment Status: Completed
Publish Date: July 05, 2018
Intervention Type: Radiation, Drug
Study Phase: Phase 1/Phase 2
View 8 Less Clinical Trials

219 Total Publications

Simultaneous Durvalumab and Platinum-Based Chemoradiotherapy in Unresectable Stage III Non-Small Cell Lung Cancer: The Phase III PACIFIC-2 Study.
Simultaneous Durvalumab and Platinum-Based Chemoradiotherapy in Unresectable Stage III Non-Small Cell Lung Cancer: The Phase III PACIFIC-2 Study.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: October 13, 2025
View All 219 Publications
Similar Doctors
Wenyin Shi
Elite in Brain Tumor
Dr. Wenyin Shi
Radiation Oncology
Elite in Brain Tumor
Dr. Wenyin Shi
Radiation Oncology

Radiation Oncology At Thomas Jefferson University Hospital

111 South 11th Street, Suite G-301, 
Philadelphia, PA 
 (1.8 miles away)
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Wenyin Shi is a Radiation Oncologist in Philadelphia, Pennsylvania. Dr. Shi is rated as an Elite provider by MediFind in the treatment of Brain Tumor. His top areas of expertise are Astrocytoma, Mycosis Fungoides, Brain Tumor, Glioblastoma, and Gamma Knife Radiosurgery. Dr. Shi is currently accepting new patients.

Distinguished in Brain Tumor
Dr. Michelle Alonso
Radiation Oncology
Distinguished in Brain Tumor
Dr. Michelle Alonso
Radiation Oncology

Penn Radiation Oncology Perelman - 2nd Floor

3400 Civic Center Boulevard, West Pavilion, 2nd Floor, 
Philadelphia, PA 
 (0.1 miles away)
800-789-7366
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Michelle Alonso is a Radiation Oncologist in Philadelphia, Pennsylvania. Dr. Alonso is rated as a Distinguished provider by MediFind in the treatment of Brain Tumor. Her top areas of expertise are Chordoma, Brain Tumor, Meningioma, Posterior Fossa Tumor, and Gamma Knife Radiosurgery. Dr. Alonso is currently accepting new patients.

Distinguished in Brain Tumor
Dr. Robert A. Lustig
Radiology | Radiation Oncology
Distinguished in Brain Tumor
Dr. Robert A. Lustig
Radiology | Radiation Oncology

University Of Penn - Medical Group

3400 Civic Ctr Blvd, 
Philadelphia, PA 
 (0.1 miles away)
215-662-2428
Languages Spoken:
English
See accepted insurances

Robert Lustig is a Radiologist and a Radiation Oncologist in Philadelphia, Pennsylvania. Dr. Lustig is rated as a Distinguished provider by MediFind in the treatment of Brain Tumor. His top areas of expertise are Astrocytoma, Glioma, Glioblastoma, and Brain Tumor.

VIEW MORE BRAIN TUMOR DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Bradley's expertise for a condition
ConditionClose
  • Elite
  • Lung Cancer
    Dr. Bradley is
    Elite
    . Learn about Lung Cancer.
    See more Lung Cancer experts
  • Non-Small Cell Lung Cancer (NSCLC)
    Dr. Bradley is
    Elite
    . Learn about Non-Small Cell Lung Cancer (NSCLC).
    See more Non-Small Cell Lung Cancer (NSCLC) experts
  • Distinguished
  • ALK-Positive Non-Small Cell Lung Cancer
    Dr. Bradley is
    Distinguished
    . Learn about ALK-Positive Non-Small Cell Lung Cancer.
    See more ALK-Positive Non-Small Cell Lung Cancer experts
  • Lung Nodules
    Dr. Bradley is
    Distinguished
    . Learn about Lung Nodules.
    See more Lung Nodules experts
  • Pleuropulmonary Blastoma
    Dr. Bradley is
    Distinguished
    . Learn about Pleuropulmonary Blastoma.
    See more Pleuropulmonary Blastoma experts
  • Small Cell Lung Cancer (SCLC)
    Dr. Bradley is
    Distinguished
    . Learn about Small Cell Lung Cancer (SCLC).
    See more Small Cell Lung Cancer (SCLC) experts
  • Squamous Cell Lung Carcinoma
    Dr. Bradley is
    Distinguished
    . Learn about Squamous Cell Lung Carcinoma.
    See more Squamous Cell Lung Carcinoma experts
  • Thymic Epithelial Tumor
    Dr. Bradley is
    Distinguished
    . Learn about Thymic Epithelial Tumor.
    See more Thymic Epithelial Tumor experts
  • Advanced
  • Astrocytoma
    Dr. Bradley is
    Advanced
    . Learn about Astrocytoma.
    See more Astrocytoma experts
  • Atypical Teratoid Rhabdoid Tumor (ATRT)
    Dr. Bradley is
    Advanced
    . Learn about Atypical Teratoid Rhabdoid Tumor (ATRT).
    See more Atypical Teratoid Rhabdoid Tumor (ATRT) experts
  • Brain Tumor
    Dr. Bradley is
    Advanced
    . Learn about Brain Tumor.
    See more Brain Tumor experts
  • Choroid Plexus Papilloma
    Dr. Bradley is
    Advanced
    . Learn about Choroid Plexus Papilloma.
    See more Choroid Plexus Papilloma experts
  • Diffuse Midline Glioma H3 K27M-Mutant
    Dr. Bradley is
    Advanced
    . Learn about Diffuse Midline Glioma H3 K27M-Mutant.
    See more Diffuse Midline Glioma H3 K27M-Mutant experts
  • EGFR Positive Lung Cancer
    Dr. Bradley is
    Advanced
    . Learn about EGFR Positive Lung Cancer.
    See more EGFR Positive Lung Cancer experts
View All 18 Advanced Conditions
  • Experienced
  • Adrenal Cancer
    Dr. Bradley is
    Experienced
    . Learn about Adrenal Cancer.
    See more Adrenal Cancer experts
  • Adult Soft Tissue Sarcoma
    Dr. Bradley is
    Experienced
    . Learn about Adult Soft Tissue Sarcoma.
    See more Adult Soft Tissue Sarcoma experts
  • Alveolar Soft Part Sarcoma
    Dr. Bradley is
    Experienced
    . Learn about Alveolar Soft Part Sarcoma.
    See more Alveolar Soft Part Sarcoma experts
  • Angiosarcoma
    Dr. Bradley is
    Experienced
    . Learn about Angiosarcoma.
    See more Angiosarcoma experts
  • Angiosarcoma of the Scalp
    Dr. Bradley is
    Experienced
    . Learn about Angiosarcoma of the Scalp.
    See more Angiosarcoma of the Scalp experts
  • Bone Tumor
    Dr. Bradley is
    Experienced
    . Learn about Bone Tumor.
    See more Bone Tumor experts
View All 38 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2026 All Rights Reserved

    Request an Appointment

    If you are experiencing a medical emergency, call 9-1-1.

    MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

    Patient Details

    This information is for the patient who will be seen at the appointment.

      Close

      Returning patient? Use your address on file with the provider.

      Insurance Details

      Please provide information of the primary insurance holder as the practice may require this information to schedule.

      Insurance Provider *
      Insurance ProviderClose

      Appointments Details

      Let’s get more information about your appointment.

              0 / 1000
              0 / 1000
              By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.